ICsense Reports Record Growth as Demand Rises for Specialized Medical ASICs
semiconductor-digest.com Nov 11, 2026

ICsense Reports Record Growth as Demand Rises for Specialized Medical ASICs

AI-summarised brief · reviewed before publication

ICsense, a TDK Group subsidiary and Europe’s leading fab‑independent design house, posted its strongest financial results in 22 years, with revenue up 30 % and profit rising over 50 %. The surge stems from growing demand for highly customised analogue and mixed‑signal ASICs used in brain‑computer interfaces, neuromodulation, neural recording and other implantable neuro‑technologies. As major foundries shift toward high‑volume, advanced‑node projects, customers developing low‑volume medical chips have turned to ICsense for end‑to‑end design‑to‑production support across multiple foundries. The company expanded its workforce by 10 % and plans to invest in advanced manufacturing, test equipment and cleanroom capacity over the next five years to sustain its niche market leadership.

💡 Why It Matters

  • · ICsense’s fab‑independent model offers a rare, reliable supply path for low‑volume medical ASICs, filling a gap left by larger foundries that are abandoning niche processes.